Clinical Interests

Down syndrome; dual diagnosis Down syndrome; autism

Research Interests

Investigator with Dr. Cynthia Molloy and Dr. Bonnie Patterson, 2005-present, Blood Expression in Children with Down syndrome with and without autism.

Investigator with Dr. Mark Schapiro, Dr. Michael Miles and Dr. Bonnie Patterson, 2003-present, Evaluation of Coenzyme Q10 (LiQ-NOL) Efficacy in Pediatric Patients with Down Syndrome

Investigator with Dr. Mark Schapiro and Dr. Bonnie Patterson, 2004-present, Functional MRI and Language Development in Down Syndrome

Investigator with Dr Mark Schapiro and Dr. Bonnie Patterson on Assessment of Gene Expression in Persons with Down Syndrome Utilizing Microarray Technology, 2002-2003

Investigator with Dr Bonnie Patterson and Dr Richard Strawsberg on Prolonged EEG 's in Children with Down syndrome with Autism, 1999-2002

BA: Harvard University, 1978.

MD: University of Cincinnati College of Medicine, Cincinnati, OH, 1984.

Residency: Children's Hospital Medical Center, Cincinnati, OH.

Fellowship: The Children's Hospital, Boston, MA, 1989.

Molloy CA, Murray DS, Kinsman A, Castillo H, Mitchell T, Hickey FJ, Patterson B. Differences in the clinical presentation of Trisomy 21 with and without autism. J Intellect Disabil Res. 2009 Feb;53(2):143-51.

Molloy CA, Murray DS, Kinsman A, Castillo H, Mitchell T, Hickey FJ, Patterson B. Differences in the clinical presentation of Trisomy 21 with and without autism. J Intellect Disabil Res. 2008 Dec 2.

Castillo H, Patterson B, Hickey F, Kinsman A, Howard JM, Mitchell T, Molloy CA.  Difference in age at regression in children with autism with and without Down syndrome. J Dev Behav Pediatr. 2008 Apr;29(2):89-93.

Miles MV, Patterson BJ, Chalfonte-Evans ML, Horn PS, Hickey FJ, Schapiro MB, Steele PE, Tang PH, Hotze SL. Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21. Pediatr Neurol. 2007 Dec;37(6):398-403.

Miles MV, Patterson BJ, Schapiro MB, Hickey FJ, Chalfonte-Evans M, Horn PS, Hotze SL. Coenzyme Q10 absorption and tolerance in children with Down syndrome: a dose-ranging trial. Pediatr Neurol. 2006 Jul;35(1):30-7.

Miles MV, Patterson BJ, Schapiro M, Hickey FJ, et al. Evaluation of Coenzyme Q10 (LiQ-NOL) Efficacy in Pediatric Patients with Down Syndrome. Pediatric Neurology. 2006.

Tang Y, Shapiro MB, Franz DN, Patterson BJ, Hickey FJ, Schorry EK, Hopkins RJ, Wylie M, Narayan T, Glauser TA, Gilbert DL, Hershey AD, Sharp FR. Blood expression profiles for tuberous sclerosis complex 2, neurofibromatos type 1, and Down syndrome. Ann Neurol. 2004 Dec;56(6):808-14.

Goldberg H, Strawsberg R, Patterson B, Hickey F, Degraw T. Seizure frequency and characteristics in children with Down syndrome. Brain and Development. 2001 23;375-378.

Vaughn L, Schultz J, Burklow K, Hickey F, Lanphear N, and R Baker. Preparing pediatric residents to meet the behavioral developmental needs of parents and children: evaluating the impact of an intensive seminar. Submitted to Archives of Pediatric and Adolescent Medicine. Jan 2001.